• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: JOHNSON & JOHNSON VISION CARE, INC. - US ACUVUE OASYS; LENSES, SOFT CONTACT, EXTENDED WEAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

JOHNSON & JOHNSON VISION CARE, INC. - US ACUVUE OASYS; LENSES, SOFT CONTACT, EXTENDED WEAR Back to Search Results
Catalog Number PH
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Bacterial Infection (1735); Corneal Ulcer (1796); Vitreous Floaters (1866); Foreign Body Sensation in Eye (1869); Hypoxia (1918); Keratitis (1944)
Event Date 12/10/2020
Event Type  Injury  
Manufacturer Narrative
Suspect discarded by the patient.
 
Event Description
On 15jan2021 a patient (pt) called to report a diagnosis of os corneal ulcer while wearing the acuvue® oasys with hydraclear® plus brand contact lenses (cls).The pt reported sleeping in the lenses for ¿a while¿ and experienced os foreign body sensation.The pt went to an urgent care, prescribed cipro, and referred to an ophthalmologist.The pt reported the symptoms began (b)(6) 2020 and went to ophthalmologist on (b)(6) 2020.Per the pts discharge papers, the pt was diagnosed with an os corneal ulcer, location of ulcer not provided.The pt was prescribed ciprofloxacin five times a day or 2 drops every 4 hours for 5 days; white spot floaters; scar superiorly, old ulcer; infection of bacterial; inflammation of the cornea over wear of cls; hypoxia, no lens wear for the period of treatment; clear to use cls after treatment; switched to biofinity cls.The pt was reported using biofinity lenses in the past, sleeping in lenses and never had an issue with the lenses.Pt is currently using lenses and the ulcer and scar healed well.The pt has a follow-up appointment in a year.The pt agreed to sign a medical release form at the treating ophthalmologist office to provide additional information.On 19jan2021 a call was placed to the pts treating ophthalmologist office and a representative advised the pt must sign a medical release form to allow the release of any medical information.No additional information was provided.On 09feb2021 a call was placed to the pt to determine what cls brand the pt was wearing at the time of the ¿superior scar, old ulcer¿ provided from the discharge papers.The pt reported there was no previous ulcer or scar.The pt began wearing the acuvue® oasys® brand cls in (b)(6) 2020 and discontinued wear in (b)(6) 2020.The only event the pt experienced was the os corneal ulcer event in (b)(6) 2020 while wearing the acuvue® oasys® brand cls.The pt wore the air optix brand cls prior to acuvue® oasys® brand cls wear, not biofinity as previously reported.The pt is currently wearing air optix cls.The pt refused to release any medical information from the treating ophthalmologist.No additional medical information was provided.No additional medical information is expected.A lot history review was performed and revealed the following: the batch record did not show any abnormalities in monomer and solution testing.All parameters tested were within specification.All sterilization requirements were successfully completed.Lot b00txbd was produced under normal conditions.The suspect os contact lens was discarded.No additional evaluation can be conducted.If any further relevant information is received, a supplemental report will be filed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACUVUE OASYS
Type of Device
LENSES, SOFT CONTACT, EXTENDED WEAR
Manufacturer (Section D)
JOHNSON & JOHNSON VISION CARE, INC. - US
7500 centurion parkway
jacksonville FL 32256
Manufacturer Contact
rose harrell
7500 centurion parkway
jacksonville, FL 32256
9044433647
MDR Report Key11308924
MDR Text Key238344228
Report Number1057985-2021-00110
Device Sequence Number1
Product Code LPM
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P040045
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 02/10/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/10/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Catalogue NumberPH
Device Lot NumberB00TXBD
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received01/15/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/26/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
Patient Age41 YR
-
-